N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles

Details for Australian Patent Application No. 2008239841 (hide)

Owner NSAB, Filial af NeuroSearch Sweden AB, Sverige

Inventors Wikstrom, Hakan V.

Agent Davies Collison Cave

Pub. Number AU-A-2008239841

PCT Pub. Number WO2008/127188

Priority 0700893-1 12.04.07 SE

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

C07D 211/94 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/127188 Priority application(s): WO2008/127188

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239850-Multi-storey building design

2008239833-Use of selected lactic acid bacteria for reducing atherosclerosis